CAPTRUST Financial Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,184
Closed -$41K 2635
2025
Q2
$41K Buy
+10,184
New +$33.1K ﹤0.01% 2444
2024
Q4
Sell
-11,671
Closed -$34.3K 2302
2024
Q3
$34.3K Sell
11,671
-630
-5% -$2K ﹤0.01% 2251
2024
Q2
$42.8K Sell
12,301
-101
-0.8% -$337 ﹤0.01% 2154
2024
Q1
$35.3K Buy
+12,402
New +$38.3K ﹤0.01% 2098
2022
Q3
Sell
-2,155
Closed -$10K 2298
2022
Q2
$10K Sell
2,155
-85
-4% -$613 ﹤0.01% 3736
2022
Q1
$19K Buy
2,240
+285
+15% +$2K ﹤0.01% 3413
2021
Q4
$17K Hold
1,955
﹤0.01% 3396
2021
Q3
$20K Hold
1,955
﹤0.01% 3164
2021
Q2
$21K Hold
1,955
﹤0.01% 3063
2021
Q1
$20K Buy
+1,955
New +$27.2K ﹤0.01% 2991

Other funds holding SRTA

CAPTRUST Financial Advisors's SRTA Position: Q3 2025 in Review

CAPTRUST Financial Advisors sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 10,184 shares — an estimated $41K sold.

CAPTRUST Financial Advisors first reported a position in SRTA in Q1 2021 and held it in 10 quarters. The position peaked at $42.8K in Q2 2024. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • CAPTRUST Financial Advisors reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,184 Strata Critical Medical Inc shares in Q3 2025, an estimated $41K.
  • CAPTRUST Financial Advisors first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Strata Critical Medical Inc position peaked at $42.8K in Q2 2024.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2025, filed 19 Nov 2025.